AI-Powered blood test could spot colon cancer before it spreads
NCT ID NCT06889883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create a blood test that can detect colorectal cancer and advanced polyps early. Researchers will use artificial intelligence to combine molecular markers and personal risk factors. The test will be developed and validated in 510 adults undergoing colonoscopy or surgery. If successful, it could offer a less invasive screening option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ADENOMAS (AA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Centro Médico de Asturias
RECRUITINGOviedo, Principality of Asturias, Spain
-
Hospital Clinico Universitario Lozano Blesa
RECRUITINGZaragoza, Aragon, Spain
-
Hospital Sant Rafael
COMPLETEDBarcelona, Catalonia, Spain
-
Hospital Universitario Marques de Valdecilla
TERMINATEDSantander, Cantabria, Spain
-
Hospital Universitario Vall d' Hebron
COMPLETEDBarcelona, Catalonia, Spain
-
Hospital Universitario de Cruces
RECRUITINGBilbao, Basque Country, Spain
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Castille and León, Spain
-
MD Anderson Cancer Centre
ACTIVE_NOT_RECRUITINGMadrid, Madrid, Spain
-
Policlinica Gipuzkoa Hospital
COMPLETEDDonostia / San Sebastian, Basque Country, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?